- Home
- NECB vs NMRA Comparison
NECB vs NMRA Comparison
Compare NECB & NMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NECB
- NMRA
- Stock Information
- Founded
- NECB 1934
- NMRA 2019
- Country
- NECB United States
- NMRA United States
- Employees
- NECB N/A
- NMRA N/A
- Industry
- NECB Savings Institutions
- NMRA
- Sector
- NECB Finance
- NMRA
- Exchange
- NECB Nasdaq
- NMRA Nasdaq
- Market Cap
- NECB 281.2M
- NMRA 121.0M
- IPO Year
- NECB N/A
- NMRA 2023
- Fundamental
- Price
- NECB $23.79
- NMRA $1.26
- Analyst Decision
- NECB
- NMRA Buy
- Analyst Count
- NECB 0
- NMRA 8
- Target Price
- NECB N/A
- NMRA $9.29
- AVG Volume (30 Days)
- NECB 33.8K
- NMRA 1.6M
- Earning Date
- NECB 07-21-2025
- NMRA 08-05-2025
- Dividend Yield
- NECB 3.37%
- NMRA N/A
- EPS Growth
- NECB 0.72
- NMRA N/A
- EPS
- NECB 3.44
- NMRA N/A
- Revenue
- NECB $104,392,000.00
- NMRA N/A
- Revenue This Year
- NECB $2.80
- NMRA N/A
- Revenue Next Year
- NECB $8.34
- NMRA N/A
- P/E Ratio
- NECB $6.90
- NMRA N/A
- Revenue Growth
- NECB 2.77
- NMRA N/A
- 52 Week Low
- NECB $17.94
- NMRA $0.61
- 52 Week High
- NECB $31.72
- NMRA $17.19
- Technical
- Relative Strength Index (RSI)
- NECB 60.18
- NMRA 69.27
- Support Level
- NECB $23.83
- NMRA $0.72
- Resistance Level
- NECB $24.81
- NMRA $1.18
- Average True Range (ATR)
- NECB 0.69
- NMRA 0.10
- MACD
- NECB 0.12
- NMRA 0.03
- Stochastic Oscillator
- NECB 79.71
- NMRA 74.14
About NECB NorthEast Community Bancorp Inc.
NorthEast Community Bancorp Inc operates as a community-oriented financial institution. It is principally engaged in the business of attracting deposits and investing those funds into mortgage and commercial loans. It conducts activities throughout the Northeastern United States including New York, Massachusetts, New Jersey, and Connecticut. The company offers a comprehensive line of banking products and services, including mobile banking as well as commercial real estate loans, commercial construction financing, lines of credit, and term loans. It also offers investment advisory and financial planning services.
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.